FDA promises quick review of Pfizer booster for all adults, CDC meets Friday

Slideshow ( 2 images )(Reuters) -The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc’s request to authorize booster doses of COVID-19 vaccine in all adults “as expeditiously as possible,” with the New York Times here reporting that the regulatory nod could come as soon as Thursday. The agency said it does not plan to […]
Continue reading »